- 全部删除
- 您的购物车当前为空
BTK-IN-30 (compound cpd15) serves as an inhibitor targeting both Bruton's Tyrosine Kinase (BTK) and its mutant forms, exhibiting IC50 values of 6.72 nM and 6.11 nM, respectively [1].
BTK-IN-30 (compound cpd15) serves as an inhibitor targeting both Bruton's Tyrosine Kinase (BTK) and its mutant forms, exhibiting IC50 values of 6.72 nM and 6.11 nM, respectively [1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | BTK-IN-30 (compound cpd15) serves as an inhibitor targeting both Bruton's Tyrosine Kinase (BTK) and its mutant forms, exhibiting IC50 values of 6.72 nM and 6.11 nM, respectively [1]. |
分子量 | 453.44 |
分子式 | C23H21F2N5O3 |
CAS No. | 2662512-15-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容